InvestorsHub Logo
Followers 7
Posts 685
Boards Moderated 0
Alias Born 12/23/2010

Re: None

Friday, 09/02/2011 4:50:51 PM

Friday, September 02, 2011 4:50:51 PM

Post# of 636
Press Release

News for 'HGSI' - (Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Baird Conference)


ROCKVILLE, Md., Sep 02, 2011 (BUSINESS WIRE) -- Human Genome Sciences, Inc.
(NASDAQ: HGSI) announced today that its presentation at Baird's 2011 Health Care
Conference will be webcast and may be accessed at www.hgsi.com.

A member of Human Genome Sciences' senior management team will present a
corporate overview on Thursday, September 8, 2011, at 9:00 AM Eastern time.
Investors interested in listening to the live webcast should log on before the
start time in order to download any software required. The archive of the
webcast will be available for several days after the live event.

ABOUT HUMAN GENOME SCIENCES

Human Genome Sciences exists to place new therapies into the hands of those
battling serious disease.

For more information about HGS, please visit the Company's web site at
www.hgsi.com. Health professionals and patients interested in clinical trials of
HGS products may inquire via e-mail to medinfo@hgsi.com or by calling HGS at
(877) 822-8472.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.
Other trademarks referenced are the property of their respective owners.

SOURCE: Human Genome Sciences, Inc.



CON TACT:
Human Genome Sciences
Media Contacts:
Susannah Budington
Director, Corporate Public Relations
301-545-1062
or
Jerry Parrott
Vice President, Corporate Communications
301-315-2777
or
Investor Contacts:
Claudine Prowse, Ph.D.
Executive Director, Investor Relations
301-315-1785
or
Peter Vozzo
Senior Director, Investor Relations
301-251-6003




Copyright Business Wire 2011

-0-




KEYWORD: United States

North America

Maryland

New York

INDUSTRY KEYWORD: Health

Biotechnology

SUBJECT CODE: Conference

Trade Show

Webcast


All my posts are based on my own opinions. Do your own DD before purchasing or selling any stock.